EP2320940 - ANTICORPS HUMAINS QUI SE LIENT AU GÈNE 3 D'ACTIVATION DES LYMPHOCYTES (LAG-3), ET LEURS UTILISATIONS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 08.01.2016 Database last updated on 26.04.2025 | Most recent event Tooltip | 08.01.2016 | No opposition filed within time limit | published on 10.02.2016 [2016/06] | Applicant(s) | For all designated states E. R. Squibb & Sons, L.L.C. Route 206 and Province Line Road Princeton, NJ 08540 / US | [2014/51] |
Former [2013/31] | For all designated states Medarex, L.L.C. Route 206 and Province Line Road Princeton, NJ 08540 / US | ||
Former [2011/20] | For all designated states Medarex, Inc. Route 206 & Province Line Road Princeton, NJ 08540 / US | Inventor(s) | 01 /
THUDIUM, Kent, B. 521 Cottonwood Drive Milpitas, CA 95035 / US | 02 /
KORMAN, Alan, J. 521 Cottonwood Drive Milpitas, CA 95035 / US | 03 /
LEBLANC, Heidi 521 Cottonwood Drive Milpitas, CA 95035 / US | 04 /
YAMANAKA, Mark 521 Cottonwood Drive Milpitas, CA 95035 / US | 05 /
SELBY, Mark 521 Cottonwood Drive Milpitas, CA 95035 / US | 06 /
ZENS, Kyra, D. 521 Cottonwood Drive Milpitas, CA 95035 / US | [2011/20] | Representative(s) | Reitstötter Kinzebach Patentanwälte Sternwartstraße 4 81679 München / DE | [N/P] |
Former [2015/10] | Reitstötter Kinzebach Patentanwälte Sternwartstrasse 4 81679 München / DE | ||
Former [2011/20] | Reitstötter - Kinzebach Patentanwälte Sternwartstrasse 4 81679 München / DE | Application number, filing date | 09807162.4 | 11.08.2009 | [2011/20] | WO2009US53405 | Priority number, date | US20080188548P | 11.08.2008 Original published format: US 188548 P | [2011/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2010019570 | Date: | 18.02.2010 | Language: | EN | [2010/07] | Type: | A2 Application without search report | No.: | EP2320940 | Date: | 18.05.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.02.2010 takes the place of the publication of the European patent application. | [2011/20] | Type: | B1 Patent specification | No.: | EP2320940 | Date: | 04.03.2015 | Language: | EN | [2015/10] | Search report(s) | International search report - published on: | US | 17.06.2010 | (Supplementary) European search report - dispatched on: | EP | 21.12.2012 | Classification | IPC: | C12N5/16 | [2014/34] | CPC: |
C07K16/2803 (EP,CN,IL,KR,US);
A61P31/12 (EP,IL);
A61P31/18 (EP,IL);
A61P35/00 (EP,IL,KR);
A61P35/02 (EP,IL);
A61P37/00 (EP,IL);
A61P37/04 (EP,IL);
A61P43/00 (EP,IL);
C07K16/2827 (EP,IL,US);
A61K2039/505 (EP,IL,KR,US);
A61K2039/507 (EP,IL,US);
C07K2317/21 (EP,IL,KR,US);
C07K2317/33 (KR);
C07K2317/34 (EP,IL,US);
C07K2317/73 (EP,IL,KR,US);
|
Former IPC [2013/04] | A61K39/00, C07K17/00, A61K39/395, A61K51/10, C07K16/28 | ||
Former IPC [2011/20] | A61K39/00, C07K17/00, A61K39/395 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2011/20] | Title | German: | LYMPHOZYTENAKTIVIERUNGSGEN-3 (LAG-3) BINDENDE HUMANE ANTIKÖRPER UND IHRE VERWENDUNG | [2011/20] | English: | HUMAN ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF | [2011/20] | French: | ANTICORPS HUMAINS QUI SE LIENT AU GÈNE 3 D'ACTIVATION DES LYMPHOCYTES (LAG-3), ET LEURS UTILISATIONS | [2011/20] | Entry into regional phase | 02.02.2011 | National basic fee paid | 02.02.2011 | Search fee paid | 02.02.2011 | Designation fee(s) paid | 02.02.2011 | Examination fee paid | Examination procedure | 02.02.2011 | Examination requested [2011/20] | 09.07.2013 | Amendment by applicant (claims and/or description) | 26.08.2013 | Despatch of a communication from the examining division (Time limit: M06) | 19.02.2014 | Reply to a communication from the examining division | 01.04.2014 | Despatch of a communication from the examining division (Time limit: M04) | 16.05.2014 | Reply to a communication from the examining division | 22.07.2014 | Communication of intention to grant the patent | 21.11.2014 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 17.12.2014 | Communication of intention to grant the patent | 19.01.2015 | Fee for grant paid | 19.01.2015 | Fee for publishing/printing paid | 19.01.2015 | Receipt of the translation of the claim(s) | Divisional application(s) | EP15156647.8 / EP2905030 | EP19186310.9 / EP3597216 | EP22185991.1 / EP4147714 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 26.08.2013 | Opposition(s) | 07.12.2015 | No opposition filed within time limit [2016/06] | Fees paid | Renewal fee | 11.08.2011 | Renewal fee patent year 03 | 10.08.2012 | Renewal fee patent year 04 | 19.08.2013 | Renewal fee patent year 05 | 13.08.2014 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XAI]WO9110682 (INST NAT SANTE RECH MED [FR], et al); | [XAI]WO9530750 (ROUSSY INST GUSTAVE [FR], et al); | International search | [A]WO9703695 (APPLIED RESEARCH SYSTEMS [AN], et al); | [A]US6143273 (FAURE FLORENCE [FR], et al); | [A]WO0069914 (OXFORD BIOMEDICA LTD [GB], et al); | [Y]US6197524 (ROMAGNANI SERGIO [IT]); | [A]US2002086014 (KORMAN ALAN J [US], et al); | [A]US2002146753 (DITZEL HENRIK [US], et al); | [A]US2003059937 (RUBEN STEVEN M [US], et al); | [A]US2003129601 (COLE STEWART T [FR]); | [A]US2004072164 (MARUYAMA TOSHIAKI [US], et al); | [A]US2005009136 (NIXON ANDREW [US], et al); | [A]WO2005034733 (LONG ISLAND JEWISH RES INST [US], et al); | [A]US2005226876 (GRAUS YVO [NL], et al); | [A]WO2006007850 (SYMPHOGEN AS [DK], et al); | [Y]US2006177442 (VON STRANDMANN ELKE P [DE], et al); | [X]US2006240024 (PARDOLL DREW M [US], et al); | [A]US2007004910 (SEXTON DANIEL J [US], et al); | [A]US2007160598 (DENNIS MARK S [US], et al); | [A]WO2008007648 (INST ANTIBODIES CO LTD [JP], et al); | [A]US2008069822 (JENSEN ALLAN [DK], et al); | [AE]WO2008132601 (IMMUTEP [FR], et al); |